Overexpression of peroxiredoxin 4 attenuates atherosclerosis in apolipoprotein e knockout mice

Antioxidants and Redox Signaling

Volumn 17, Issue 10, 2012, Pages 1362-1375

  Guo, Xin ^a   Yamada, Sohsuke ^a   Tanimoto, Akihide ^a,b   Ding, Yan ^a,c   Wang, Ke Yong ^a   Shimajiri, Shohei ^a   Murata, Yoshitaka ^d   Kimura, Satoshi ^a   Tasaki, Takashi ^a   Nabeshima, Atsunori ^a   Watanabe, Teruo ^e   Kohno, Kimitoshi ^f   Sasaguri, Yasuyuki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d Kyurin Corporation   (Japan)

^e FUKUOKA WAJIRO HOSPITAL   (Japan)

^f UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA SMOOTH MUSCLE ACTIN; APOLIPOPROTEIN E; BETA ACTIN; BIOLOGICAL MARKER; COLLAGEN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE 3; GLUTATHIONE REDUCTASE; GLUTATHIONE SYNTHASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXIREDOXIN 4; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DISEASE COURSE; EXTRACELLULAR SPACE; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; KNOCKOUT MOUSE; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; OXIDATIVE STRESS; PEROXIREDOXINS; REACTIVE OXYGEN SPECIES;

MUS;

EID: 84866279008     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4549     Document Type: Article

References (34)

1. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, Park HS, Kim KY, Lee JS, Choi C, Bae YS, Lee BI, Rhee SG, and Kang SW. Regulation of PDGF signaling and vascular remodeling by peroxiredoxin II. Nature 435: 347-353, 2005. (Pubitemid 40745544)
2. de Haan JB, Witting PK, Stefanovic N, Pete J, Daskalakis M, Kola I, Stocker R, and Smolich JJ. Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL/J6 mice fed a high-fat diet. J Lipid Res 47: 1157-1167, 2006. (Pubitemid 43830707)
3. Ding Y, Yamada S, Wang KY, Shimajiri S, Guo X, Tanimoto A, Murata Y, Kitajima S, Watanabe T, Izumi H, Kohno K, and Sasaguri Y. Overexpression of peroxiredoxin 4 protects against high-dose streptozotocin-induced diabetes by suppressing oxidative stress and cytokines in transgenic mice. Antioxid Redox Signal 13: 1477-1490, 2010.
4. Guevara NV, Kim HS, Antonova EI, and Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat Med 5: 335-339, 1999. (Pubitemid 29124372)
5. Iuliano L. The oxidant stress hypothesis of atherogenesis. Lipids 36: 41-44, 2001.
6. Jin DY, Chae HZ, Rhee SG, and Jeang KT. Regulatory role for a novel human thioredoxin peroxidase in NF-jB activation. J Biol Chem 272: 30952-30961, 1997. (Pubitemid 27527539)
7. Johnson JL and Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 154: 399-406, 2001. (Pubitemid 32146612)
8. Kang SW, Rhee SG, Chang TS, JeongW, and Choi MH. 2-Cys peroxiredoxin function in intracellular signal transduction: Therapeutic implications. Trends Mol Med 11: 571-578, 2005. (Pubitemid 41713999)
9. Kasai H, Kawai K, and Li YS. Analysis of 8-OH-dG and 8-OH-Gua as biomarkers of oxidative stress. Genes Environ 30: 33-40, 2008.
10. Kisucka J, Kisucka J, Chauhan AK, Patten IS, Yesilaltay A, Neumann C, Van Etten RA, Krieger M, and Wagner DD. Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ Res 103: 598-605, 2008.
11. Kockx MM and Herman AG. Apoptosis in atherosclerosis: Beneficial or detrimental? Cardiovasc Res 45: 736-746, 2000. (Pubitemid 30047141)
12. Libby P. Inflammation in atherosclerosis. Nature 420: 868-874, 2002. (Pubitemid 36019640)
13. Matsumoto A, Okado A, Fujii T, J Fujii J, Egashira M, Niikawa N, and Taniguchi N. Cloning of the peroxiredoxin gene family in rats and characterization of the fourth member. FEBS Lett 443: 246-250, 1999. (Pubitemid 29080804)
14. Meier JL and Stinski MF. Regulation of human cytomegalovirus immediate-early gene expression. Intervirology 39: 331-342, 1996. (Pubitemid 27174136)
15. Moore KJ, Kunjathoor VV, Koehn SL, Manning JJ, Tseng AA, Silver JM, McKee M, and Freeman MW. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways dose not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 115: 2192-2201, 2005. (Pubitemid 41134161)
16. Ovchinnikova O, Robertson AK, Wagsä ter D, Folco EJ, Hyry M, Myllyharju J, Eriksson P, Libby P, and Hansson GK. Tcell activation leads to reduced collagen maturation in atherosclerotic plaques of ApoE-/-mice. Am J Pathol 174: 693-700, 2009.
17. Rhee SG, Chae HZ, and Kim K. Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552, 2005. (Pubitemid 40726061)
18. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 340: 115-126, 1999.
19. Sasaguri Y, Wang KY, Tanimoto A, Tsutsui M, Ueno H, Murata Y, Kohno Y, Yamada S, and Ohtsu H. Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis. Circ Res 96: 974-981, 2005. (Pubitemid 40712797)
20. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, and Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8: 403-409, 2002. (Pubitemid 34407037)
21. Scoccia AE, Molinuevo MS, McCarthy AD, and Cortizo AM. A simple method to assess the oxidative susceptibility of low density lipoproteins. BMC Clin Pathol 1: 1, 2001.
22. Seimon T and Tabas I. Mechanisms and consequences of macrophage apoptosis in atherosclerosis. J Lipid Res 50: S382-S387, 2009.
23. Takahashi M, Shimajiri S, Izumi H, Hirano G, Kashiwagi E, Yasuniwa Y, Wu Y, Han B, Akiyama M, Nishizawa S, Sasaguri Y, and Kohno K. Y-box binding protein-1 is a novel molecular target for tumor vessels. Cancer Sci 101: 1367-1373, 2010.
24. Thyberg J, Ostman A, Backstrom G, Westermark B, and Heldin CH. Localization of platelet-derived growth factor (PDGF) in CHO cells transfected with PDGF A-and B-chain cDNA: Retention of PDGF-BB in the endoplasmic reticulum and Golgi complex. J Cell Sci 97: 219-229, 1990. (Pubitemid 20361402)
25. Tribble DL, Barcellos-Hoff MH, Chu BM, and Gong EL. Ionizing radiation accelerates aortic lesion formation in fat-fed mice via SOD-inhibitable processes. Arterioscler Thromb Vasc Biol 19: 1387-1392, 1999. (Pubitemid 29263007)
26. Van der Wal AC, Becker AE, van der Loos CM, and Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89: 36-44, 1994. (Pubitemid 24026469)
27. Wang KY, Tanimoto A, Guo X, Yamada S, Shimajiri S, Murata Y, Ding Y, Tsutsui T, Kato S, Watanabe T, Ohtsu H, Hirano KI, Kohno K, and Sasaguri Y. Histamine deficiency decrease atherosclerosis and inflammatory response in apolipoprotein E knockout mice independently of serum cholesterol level. Arterioscler Thromb Vasc Biol 31: 800-807, 2011.
28. Wang X, Phelan SA, Petros C, Taylor EF, Ledinski G, Jurgens G, Forsman-Semb K, and Paigen B. Peroxiredoxin 6 deficiency and atherosclerosis susceptibility in mice: Significance of genetic background for assessing atherosclerosis. Atherosclerosis 177: 61-70, 2004. (Pubitemid 39361139)
29. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 344: 793-795, 1994. (Pubitemid 24283962)
30. Yamada S, Ding Y, and Sasaguri Y. Peroxiredoxin 4: Critical roles in inflammatory diseases. J UOEH 34: 27-39, 2012.
31. Yamada S, Ding Y, Tanimoto A, Wang KY, Guo X, Li Z, Tasaki T, Nabesima A, Murata Y, Shimajiri S, Kohno K, Ichijo H, and Sasaguri Y. Apoptosis signal-regulating kinase 1 deficiency accelerates hyperlipidemia-induced atheromatous plaques via suppression of macrophage apoptosis. Arterioscler Thromb Vasc Biol 31: 1555-1564, 2011.
32. Yamada S, Wang KY, Tanimoto A, Fan J, Shimajiri S, Kitajima S, Morimoto M, Tsutui M, Watanabe T, Yasumoto K, and Sasaguri Y. Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits. Am J Pathol 172: 1419-1429, 2008. (Pubitemid 351671554)
33. Yang H, Roberts LJ, Shi ML, Zhou LC, Ballard BR, Richardson A, and Guo ZM. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ Res 95: 1075-1081, 2004. (Pubitemid 39557894)
34. Zhang L, Liu Y, Zhang PF, Zhao YX, Ji XP, Lu XT, Chen WQ, Liu CX, Zhang C, and Zhang Y. Peak radial and circumferential strain measured by velocity vector imaging is a novel index for detecting vulnerable plaques in a rabbit model of atherosclerosis. Atherosclerosis 211: 146-152, 2010.